Metropolitan Life Insurance CO Pacific Biosciences Of California, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

58 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$3.52 - $9.59 $10,053 - $27,389
-2,856 Reduced 19.67%
11,666 $43,000
Q3 2023

Nov 14, 2023
BUY
$8.23 - $13.93 $6,205 - $10,503
754 Added 5.48%
14,522 $121,000
Q2 2023

Aug 10, 2023
BUY
$9.97 - $14.05 $3,878 - $5,465
389 Added 2.91%
13,768 $183,000
Q1 2023

May 15, 2023
SELL
$7.94 - $12.02 $4,239 - $6,418
-534 Reduced 3.84%
13,379 $154,000
Q4 2022

Jun 14, 2023
BUY
$5.67 - $11.2 $3,027 - $5,980
534 Added 3.99%
13,913 $114 Million
Q4 2022

Mar 30, 2023
BUY
$5.67 - $11.2 $11,186 - $22,097
1,973 Added 16.52%
13,913 $113,000
Q4 2022

Feb 15, 2023
BUY
$5.67 - $11.2 $11,186 - $22,097
1,973 Added 16.52%
13,913 $113,000
Q3 2022

Jun 14, 2023
SELL
$3.93 - $8.57 $5,655 - $12,332
-1,439 Reduced 10.76%
11,940 $69.3 Million
Q3 2022

Mar 30, 2023
SELL
$3.93 - $8.57 $6,834 - $14,903
-1,739 Reduced 12.71%
11,940 $69,000
Q3 2022

Nov 14, 2022
SELL
$3.93 - $8.57 $6,834 - $14,903
-1,739 Reduced 12.71%
11,940 $69,000
Q2 2022

Jun 20, 2023
BUY
$4.02 - $10.43 $1,205 - $3,129
300 Added 2.24%
13,679 $60,000
Q2 2022

Mar 30, 2023
BUY
$4.02 - $10.43 $6,974 - $18,096
1,735 Added 14.53%
13,679 $60,000
Q2 2022

Aug 11, 2022
BUY
$4.02 - $10.43 $6,974 - $18,096
1,735 Added 14.53%
13,679 $60,000
Q1 2022

Jun 20, 2023
SELL
$8.43 - $20.9 $12,097 - $29,991
-1,435 Reduced 10.73%
11,944 $108,000
Q1 2022

Mar 30, 2023
SELL
$8.43 - $20.9 $332,866 - $825,257
-39,486 Reduced 76.78%
11,944 $108,000
Q1 2022

May 12, 2022
SELL
$8.43 - $20.9 $332,866 - $825,257
-39,486 Reduced 76.78%
11,944 $109,000
Q4 2021

Jun 21, 2023
BUY
$19.26 - $30.08 $732,862 - $1.14 Million
38,051 Added 284.41%
51,430 $1.05 Million
Q3 2021

Jun 21, 2023
BUY
$24.86 - $35.02 $945,947 - $1.33 Million
38,051 Added 284.41%
51,430 $1.31 Million
Q3 2021

Mar 30, 2023
SELL
$24.86 - $35.02 $33,536 - $47,241
-1,349 Reduced 2.56%
51,430 $1.31 Million
Q3 2021

Nov 15, 2021
SELL
$24.86 - $35.02 $33,536 - $47,241
-1,349 Reduced 2.56%
51,430 $1.31 Million
Q2 2021

Jun 21, 2023
BUY
$22.3 - $36.02 $878,620 - $1.42 Million
39,400 Added 294.49%
52,779 $1.85 Million
Q2 2021

Mar 30, 2023
BUY
$22.3 - $36.02 $105,077 - $169,726
4,712 Added 9.8%
52,779 $1.85 Million
Q2 2021

Aug 16, 2021
BUY
$22.3 - $36.02 $1.18 Million - $1.9 Million
52,731 Added 109856.25%
52,779 $1.85 Million
Q1 2021

Jun 26, 2023
BUY
$26.38 - $51.15 $915,069 - $1.77 Million
34,688 Added 259.27%
48,067 $1.6 Billion
Q1 2021

Mar 30, 2023
SELL
$26.38 - $51.15 $39,464 - $76,520
-1,496 Reduced 3.02%
48,067 $1.6 Million
Q1 2021

May 14, 2021
SELL
$26.38 - $51.15 $1.31 Million - $2.53 Million
-49,515 Reduced 99.9%
48 $1.6 Million
Q4 2020

Jun 22, 2023
BUY
$10.5 - $28.5 $379,932 - $1.03 Million
36,184 Added 270.45%
49,563 $1.29 Million
Q4 2020

Mar 30, 2023
BUY
$10.5 - $28.5 $30,712 - $83,362
2,925 Added 6.27%
49,563 $1.29 Million
Q4 2020

Feb 16, 2021
BUY
$10.5 - $28.5 $30,712 - $83,362
2,925 Added 6.27%
49,563 $1.29 Million
Q3 2020

Jun 26, 2023
BUY
$3.61 - $9.87 $120,064 - $328,266
33,259 Added 248.59%
46,638 $460,000
Q3 2020

Mar 30, 2023
BUY
$3.61 - $9.87 $974 - $2,664
270 Added 0.58%
46,638 $460,000
Q3 2020

Nov 13, 2020
BUY
$3.61 - $9.87 $974 - $2,664
270 Added 0.58%
46,638 $460,000
Q2 2020

Jun 26, 2023
BUY
$2.65 - $4.03 $87,420 - $132,945
32,989 Added 246.57%
46,368 $159,000
Q2 2020

Mar 30, 2023
BUY
$2.65 - $4.03 $1,142 - $1,736
431 Added 0.94%
46,368 $159,000
Q2 2020

Aug 14, 2020
BUY
$2.65 - $4.03 $1,142 - $1,736
431 Added 0.94%
46,368 $160,000
Q1 2020

Jul 12, 2023
BUY
$2.36 - $5.26 $76,836 - $171,255
32,558 Added 243.35%
45,937 $140,000
Q1 2020

Mar 30, 2023
SELL
$2.36 - $5.26 $771 - $1,720
-327 Reduced 0.71%
45,937 $140,000
Q1 2020

May 15, 2020
SELL
$2.36 - $5.26 $771 - $1,720
-327 Reduced 0.71%
45,937 $141,000
Q4 2019

Jul 12, 2023
BUY
$4.6 - $5.57 $151,271 - $183,169
32,885 Added 245.8%
46,264 $237,000
Q4 2019

Mar 30, 2023
BUY
$4.6 - $5.57 $33,626 - $40,716
7,310 Added 18.77%
46,264 $237,000
Q4 2019

Feb 14, 2020
BUY
$4.6 - $5.57 $33,626 - $40,716
7,310 Added 18.77%
46,264 $238,000
Q3 2019

Jul 12, 2023
BUY
$4.99 - $6.16 $127,619 - $157,542
25,575 Added 191.16%
38,954 $201,000
Q3 2019

Mar 30, 2023
SELL
$4.99 - $6.16 $8,557 - $10,564
-1,715 Reduced 4.22%
38,954 $201,000
Q3 2019

Nov 14, 2019
SELL
$4.99 - $6.16 $8,557 - $10,564
-1,715 Reduced 4.22%
38,954 $201,000
Q2 2019

Jul 12, 2023
BUY
$5.92 - $7.41 $175,172 - $219,261
29,590 Added 221.17%
42,969 $259,000
Q1 2019

Jul 13, 2023
BUY
$6.8 - $7.4 $185,572 - $201,946
27,290 Added 203.98%
40,669 $294,000
Q1 2019

Mar 30, 2023
BUY
$6.8 - $7.4 $181,940 - $197,994
26,756 Added 192.31%
40,669 $294,000
Q1 2019

May 16, 2019
BUY
$6.8 - $7.4 $240,903 - $262,159
35,427 Added 675.83%
40,669 $294,000
Q1 2019

May 15, 2019
SELL
$6.8 - $7.4 $255,102 - $277,611
-37,515 Reduced 87.74%
5,242 $196,000
Q4 2018

Jul 13, 2023
BUY
$3.99 - $7.82 $117,218 - $229,735
29,378 Added 219.58%
42,757 $316,000
Q4 2018

Feb 14, 2019
BUY
$3.99 - $7.82 $133,704 - $262,048
33,510 Added 362.39%
42,757 $316,000
Q3 2018

Jul 13, 2023
BUY
$3.52 - $5.55 $99,612 - $157,059
28,299 Added 211.52%
41,678 $225 Million
Q3 2018

Nov 14, 2018
SELL
$3.52 - $5.55 $114,157 - $179,992
-32,431 Reduced 77.81%
9,247 $50,000
Q2 2018

Aug 15, 2018
BUY
$2.11 - $3.92 $14,879 - $27,643
7,052 Added 20.37%
41,678 $0
Q1 2018

May 15, 2018
BUY
$2.05 - $3.23 $33,453 - $52,710
16,319 Added 89.14%
34,626 $0
Q4 2017

Feb 15, 2018
BUY
$2.59 - $5.44 $47,415 - $99,590
18,307 New
18,307 $48,000
Q3 2017

Nov 14, 2017
SELL
$3.2 - $5.57 $188,857 - $328,730
-59,018 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
59,018
59,018 $210,000

Others Institutions Holding PACB

# of Institutions
254
Shares Held
228M
Call Options Held
745K
Put Options Held
1.23M
View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

PACB Quotes by TradingView
  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email